1. Home
  2. CLPS vs FGEN Comparison

CLPS vs FGEN Comparison

Compare CLPS & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLPS
  • FGEN
  • Stock Information
  • Founded
  • CLPS 2005
  • FGEN 1993
  • Country
  • CLPS Hong Kong
  • FGEN United States
  • Employees
  • CLPS N/A
  • FGEN N/A
  • Industry
  • CLPS Computer Software: Prepackaged Software
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLPS Technology
  • FGEN Health Care
  • Exchange
  • CLPS Nasdaq
  • FGEN Nasdaq
  • Market Cap
  • CLPS 35.1M
  • FGEN 34.5M
  • IPO Year
  • CLPS 2018
  • FGEN 2014
  • Fundamental
  • Price
  • CLPS $1.25
  • FGEN $0.50
  • Analyst Decision
  • CLPS
  • FGEN
  • Analyst Count
  • CLPS 0
  • FGEN 0
  • Target Price
  • CLPS N/A
  • FGEN N/A
  • AVG Volume (30 Days)
  • CLPS 21.4K
  • FGEN 885.8K
  • Earning Date
  • CLPS 03-04-2025
  • FGEN 02-24-2025
  • Dividend Yield
  • CLPS 9.85%
  • FGEN N/A
  • EPS Growth
  • CLPS N/A
  • FGEN N/A
  • EPS
  • CLPS N/A
  • FGEN N/A
  • Revenue
  • CLPS $142,812,726.00
  • FGEN $180,015,000.00
  • Revenue This Year
  • CLPS N/A
  • FGEN $21.91
  • Revenue Next Year
  • CLPS N/A
  • FGEN N/A
  • P/E Ratio
  • CLPS N/A
  • FGEN N/A
  • Revenue Growth
  • CLPS N/A
  • FGEN 16.15
  • 52 Week Low
  • CLPS $0.68
  • FGEN $0.18
  • 52 Week High
  • CLPS $1.70
  • FGEN $2.93
  • Technical
  • Relative Strength Index (RSI)
  • CLPS 60.32
  • FGEN 49.50
  • Support Level
  • CLPS $1.20
  • FGEN $0.46
  • Resistance Level
  • CLPS $1.28
  • FGEN $0.51
  • Average True Range (ATR)
  • CLPS 0.08
  • FGEN 0.05
  • MACD
  • CLPS 0.00
  • FGEN -0.01
  • Stochastic Oscillator
  • CLPS 78.89
  • FGEN 31.25

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Share on Social Networks: